Evidence map›Paper›PMID 27641977›Full record

ArticleHepatology (Baltimore, Md.)2016

Preferential association of hepatitis C virus with CD19

Richard Y Wang, Patricia Bare, Valeria De Giorgi, Kentaro Matsuura, Kazi Abdus Salam, Teresa Grandinetti, Cathy Schechterly, Harvey J Alter

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Richard Y WangDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Patricia BareDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Valeria De GiorgiDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Kentaro MatsuuraDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Kazi Abdus SalamDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Teresa GrandinettiDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Cathy SchechterlyDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Harvey J AlterDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
National Institutes of Health Clinical Center · USNagoya City University · JPUniversity of Rajshahi · BD

Funding

Study Of Anti-hepatitis C Virus Positive Blood DonorsZ01CL002068 · CLC · CLINICAL CENTER · PI ALTER, HARVEY J · 1992 to 2008
$274k
A Prospective Study Of Anti-hepatitis C Virus Positive Blood DonorsZIACL002068 · CLC · CLINICAL CENTER · PI DE GIORGI, VALERIA · 2009 to 2025
$0k
HCV Infection and Innate ImmunityZIACL002121 · CLC · CLINICAL CENTER · PI DE GIORGI, VALERIA · 2009 to 2025
$0k
Intramural NIH HHS Z01 CL002068
6 · The paper itself

Abstract

Extrahepatic disease manifestations are common in chronic hepatitis C virus (HCV) infection. The mechanism of HCV-related lymphoproliferative disorders is not fully understood. Recent studies have found that HCV in peripheral blood mononuclear cells from chronically infected patients is mainly associated with cluster of differentiation 19-positive (CD19

conclusionIn chronic HCV infection, the preferential association of HCV with B cells is mediated by the complement system, mainly through complement receptor 2 (CD21), in conjunction with the CD19 and CD81 complex. (Hepatology 2016;64:1900-1910).

Indexed as

Antigens, CD19B-LymphocytesCells, CulturedHepacivirusHepatitis C, ChronicHumansLeukocytes, MononuclearReceptors, ComplementAntigens, CD19Receptors, Complement

Identifiers

PMID27641977
PMCPMC5115962
OpenAlexW2523232989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.